Priority Tax Relief Reaches $450 Million Milestone in Active Federal and State Tax Obligations Managed September 2, 2026
K-Diet Launches Personalized Korean Diet App With Over 1,000+ Recipes and Built-In Tracking September 2, 2026
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study September 2, 2026
Two Weeks After Open-Sourcing ZSvirt, Five-Minute Trial Images Arrive as GitHub Stars Pass 1.4K September 2, 2026
Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline September 2, 2026
ROSEN, NATIONAL TRIAL COUNSEL, Encourages XTI Aerospace, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XTIA September 1, 2026
Grand Design RV launches "All Roads Lead to This" brand campaign, redefining what matters most in RVing September 1, 2026
Say Goodbye to Long-Distance Travel Fatigue – LEPAS L8 PHEV Redefines the Elegant Mobility Experience September 1, 2026
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled September 1, 2026
Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials September 1, 2026
Ronald McDonald House South East Queensland South Brisbane reaches major milestone with completion of final level September 1, 2026
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease August 31, 2026